Abiopharma

🔍 LeMaitre George W (Executive)

Company: LEMAITRE VASCULAR INC (LMAT)

Report Date: 2025-12-10

Detailed Transactions and Holdings:

• Acquired 6,275 shares of Common Stock (Direct)
  Date: 2025-12-10 | Code: A | equity_swap_involved: false | shares_owned_after: 1,670,105.00 | transaction_form_type: 4 | Footnotes: F1
• Holds 0 shares of Common Stock (Direct)
  Date: 2025-12-10 | Code: H | nature_of_ownership: LEMAITRE IRREVOCABLE LIFE INSURANCE TRUST OF 2025 | shares_owned_after: 21,300.00 | Footnotes: F2
• Acquired 38,518 shares of Stock Option (Right to Buy) at $83.66 per share (Derivative)
  Date: 2025-12-10 | Code: A | Expires: 2032-12-10 | Exercise: 2025-12-01 | equity_swap_involved: false | shares_owned_after: 38,518.00 | transaction_form_type: 4 | Footnotes: F3

Footnotes:

• F1: Represents a restricted stock unit award that vests on a time-based schedule as follows: 25% of the award vests on 12/1/2026, with the balance vesting in equal annual installments over the remaining three years. This award includes a provision for the withholding of shares by the Issuer to pay the withholding taxes due on each vesting date.
• F2: These shares are held by an irrevocable trust for the benefit of Reporting Person's child(ren). The Reporting Person disclaims ownership of such securities except to the extent of his pecuniary interest therein, if any, and the reporting herein of such securities shall not be construed as an admission of beneficial ownership thereof for the purposes of Section 16 or for any other purpose.
• F3: This option is exercisable and vests over a four-year period at a rate of 25% on the first anniversary of the date listed in the table, with the balance vesting in equal annual installments over the remaining three years.